Yu Hongmeng
Welcome,         Profile    Billing    Logout  
 0 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yu, Hongmeng
NCT06235203: Neoadjuvant Vs Adjuvant in Locally Advanced Recurrent NPC

Recruiting
3
154
RoW
endoscopic surgery, Neoadjuvant therapy,Toripalimab Injection and Gemcitabine based therapy, Adjuvant therapy in experimental group,Toripalimab Injection and Gemcitabine based therapy, Adjuvant therapy in control group,Toripalimab Injection and Gemcitabine based therapy
Eye & ENT Hospital of Fudan University, Shanghai Zhongshan Hospital, Shanghai 6th People's Hospital, Changhai Hospital, Fujian Medical University Union Hospital, People's Hospital of Guangxi, Shenzhen Second People's Hospital
Recurrent Nasopharyngeal Carcinoma
06/27
06/27
NCT06228079: Adjuvant Vs Surgery Only in Early-stage Recurrent NPC

Recruiting
3
176
RoW
Immunotherapy,Toripalimab Injection, Chemotherapy,Gemcitabine based regimen
Eye & ENT Hospital of Fudan University, Shanghai Zhongshan Hospital, Shanghai 6th People's Hospital, Changhai Hospital, Fujian Medical University Union Hospital, People's Hospital of Guangxi, Shenzhen Second People's Hospital
Recurrent Nasopharyngeal Carcinoma
06/28
06/28
NCT04215510: Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

Not yet recruiting
3
286
RoW
endonasal endoscopic surgery, radiation therapy(IMRT)
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences, Shanghai Municipal Science and Technology Commission
Recurrent Nasopharyngeal Carcinoma
03/27
03/27
ESICON, NCT06255210: Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma

Recruiting
2
25
RoW
Gemcitabine+Cisplatin(GP); Cyclophosphamide+Etoposide+Cisplatin(CEP)
Hongmeng Yu
Olfactory Neuroblastoma
03/27
03/30
NCT06861101: Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults

Recruiting
2
320
RoW
JT002 Nasal spray, Placebo
Shanghai JunTop Biosciences Co., LTD
Seasonal Allergic Rhinitis
08/25
12/25
NCT05011227: Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Recruiting
2
100
RoW
Camrelizumab, Chemotherapy, endoscopic surgery
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences
Recurrent Nasopharyngeal Carcinoma
08/25
08/25
SNMM-SA-V1, NCT04879654 / ChiCTR2100045797: Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery

Recruiting
2
45
RoW
endoscopic surgery, radiotherapy, chemotherapy, Toripalimab
Eye & ENT Hospital of Fudan University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Malignant Melanoma, Sinonasal Melanoma
05/26
05/26
NCT05350891: Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Recruiting
2
77
RoW
endoscopic surgery, adjuvant immunotherapy, chemotherapy
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences
Recurrent Nasopharyngeal Carcinoma
05/26
05/26
NCT06614686: U87 CAR-T in Patients With Advanced Head and Neck Tumors

Recruiting
1
20
RoW
U87 autologous CAR T-cell
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Nasopharynx Cancer, Head and Neck Cancer
10/26
12/27
SNMM-SA-RTNeo, NCT05009446 / ChiCTR2100049031: Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM

Recruiting
1
28
RoW
endoscopic surgery, intensity-modulated radiation therapy or volume of rotating intensity-modulated radiotherapy or Proton or heavy ion radiation therapy, Chemotherapy drug
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences
Mucosal Melanoma, Sinonasal Melanoma
08/25
08/25
NCT05421195: Clinical Treatment Research of COVID-19-related Olfactory Dysfunction

Recruiting
N/A
124
RoW
corticosteroids therapy, Olfactory training
Eye & ENT Hospital of Fudan University
Olfactory Dysfunction
02/23
03/23
NCT05448898: The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction

Recruiting
N/A
278
RoW
Traditional Chinese Medicine CU Xiu Tang, Olfactory Training
Eye & ENT Hospital of Fudan University
Olfactory Disorder
11/23
12/23
NCT05432219: A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma

Not yet recruiting
N/A
20
NA
endoscopic surgery
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences
Recurrent Nasopharyngeal Carcinoma
06/25
06/25
NCT05614375: Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus

Recruiting
N/A
40
RoW
endoscopic surgery
Eye & ENT Hospital of Fudan University
Sarcoma,Soft Tissue, Nasal Cavity Cancer, Paranasal Sinus Cancer, Surgery
06/23
06/26
NCT05627310: Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images

Recruiting
N/A
50000
RoW
Diagnostic
Eye & ENT Hospital of Fudan University, Xiangya Hospital of Central South University, The First Affiliated Hospital of Nanchang University, Fujian Medical University Union Hospital, Quan Zhou First Affiliated Hospital of Fujian Medical University, First Affiliated Hospital of Guangxi Medical University, The People' s Hospital of Guangxi Zhuang Autonomous Region, The People' s Hospital of Jiangmen
Nasopharyngeal Carcinoma
12/23
03/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Yu, Hongmeng
NCT06235203: Neoadjuvant Vs Adjuvant in Locally Advanced Recurrent NPC

Recruiting
3
154
RoW
endoscopic surgery, Neoadjuvant therapy,Toripalimab Injection and Gemcitabine based therapy, Adjuvant therapy in experimental group,Toripalimab Injection and Gemcitabine based therapy, Adjuvant therapy in control group,Toripalimab Injection and Gemcitabine based therapy
Eye & ENT Hospital of Fudan University, Shanghai Zhongshan Hospital, Shanghai 6th People's Hospital, Changhai Hospital, Fujian Medical University Union Hospital, People's Hospital of Guangxi, Shenzhen Second People's Hospital
Recurrent Nasopharyngeal Carcinoma
06/27
06/27
NCT06228079: Adjuvant Vs Surgery Only in Early-stage Recurrent NPC

Recruiting
3
176
RoW
Immunotherapy,Toripalimab Injection, Chemotherapy,Gemcitabine based regimen
Eye & ENT Hospital of Fudan University, Shanghai Zhongshan Hospital, Shanghai 6th People's Hospital, Changhai Hospital, Fujian Medical University Union Hospital, People's Hospital of Guangxi, Shenzhen Second People's Hospital
Recurrent Nasopharyngeal Carcinoma
06/28
06/28
NCT04215510: Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

Not yet recruiting
3
286
RoW
endonasal endoscopic surgery, radiation therapy(IMRT)
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences, Shanghai Municipal Science and Technology Commission
Recurrent Nasopharyngeal Carcinoma
03/27
03/27
ESICON, NCT06255210: Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma

Recruiting
2
25
RoW
Gemcitabine+Cisplatin(GP); Cyclophosphamide+Etoposide+Cisplatin(CEP)
Hongmeng Yu
Olfactory Neuroblastoma
03/27
03/30
NCT06861101: Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults

Recruiting
2
320
RoW
JT002 Nasal spray, Placebo
Shanghai JunTop Biosciences Co., LTD
Seasonal Allergic Rhinitis
08/25
12/25
NCT05011227: Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Recruiting
2
100
RoW
Camrelizumab, Chemotherapy, endoscopic surgery
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences
Recurrent Nasopharyngeal Carcinoma
08/25
08/25
SNMM-SA-V1, NCT04879654 / ChiCTR2100045797: Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery

Recruiting
2
45
RoW
endoscopic surgery, radiotherapy, chemotherapy, Toripalimab
Eye & ENT Hospital of Fudan University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Malignant Melanoma, Sinonasal Melanoma
05/26
05/26
NCT05350891: Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Recruiting
2
77
RoW
endoscopic surgery, adjuvant immunotherapy, chemotherapy
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences
Recurrent Nasopharyngeal Carcinoma
05/26
05/26
NCT06614686: U87 CAR-T in Patients With Advanced Head and Neck Tumors

Recruiting
1
20
RoW
U87 autologous CAR T-cell
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Nasopharynx Cancer, Head and Neck Cancer
10/26
12/27
SNMM-SA-RTNeo, NCT05009446 / ChiCTR2100049031: Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM

Recruiting
1
28
RoW
endoscopic surgery, intensity-modulated radiation therapy or volume of rotating intensity-modulated radiotherapy or Proton or heavy ion radiation therapy, Chemotherapy drug
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences
Mucosal Melanoma, Sinonasal Melanoma
08/25
08/25
NCT05421195: Clinical Treatment Research of COVID-19-related Olfactory Dysfunction

Recruiting
N/A
124
RoW
corticosteroids therapy, Olfactory training
Eye & ENT Hospital of Fudan University
Olfactory Dysfunction
02/23
03/23
NCT05448898: The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction

Recruiting
N/A
278
RoW
Traditional Chinese Medicine CU Xiu Tang, Olfactory Training
Eye & ENT Hospital of Fudan University
Olfactory Disorder
11/23
12/23
NCT05432219: A Transoral Retropterygoid Approach to Resect Recurrent Nasopharyngeal Carcinoma

Not yet recruiting
N/A
20
NA
endoscopic surgery
Eye & ENT Hospital of Fudan University, Chinese Academy of Medical Sciences
Recurrent Nasopharyngeal Carcinoma
06/25
06/25
NCT05614375: Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus

Recruiting
N/A
40
RoW
endoscopic surgery
Eye & ENT Hospital of Fudan University
Sarcoma,Soft Tissue, Nasal Cavity Cancer, Paranasal Sinus Cancer, Surgery
06/23
06/26
NCT05627310: Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images

Recruiting
N/A
50000
RoW
Diagnostic
Eye & ENT Hospital of Fudan University, Xiangya Hospital of Central South University, The First Affiliated Hospital of Nanchang University, Fujian Medical University Union Hospital, Quan Zhou First Affiliated Hospital of Fujian Medical University, First Affiliated Hospital of Guangxi Medical University, The People' s Hospital of Guangxi Zhuang Autonomous Region, The People' s Hospital of Jiangmen
Nasopharyngeal Carcinoma
12/23
03/24

Download Options